Table 3.
Comparative studies between the antibacterial and anticancer activity of b-AgNPs synthesized by Olax scandens leaf extract with published & commercially available silver nanoparticles.
| Synthesis of silver nanoparticles (AgNPs) | Shape with size (nm) | Bacterial activity (E. coli) (MIC, MBC in µg/mL & ZOI in mm) | Cellular toxicity IC50 (µg/mL) |
|---|---|---|---|
| Bacterium, B. Licheniformis13 | Spherical; (2-100) |
- | 500.0 nM, Antiangiogenic toxicity in Bovine retinal endothelial cells (BRECs) |
| Olax scandens leaf extract (Green chemistry methods)* | Spherical; (5-60) |
MIC & MBC: 5.0 ZOI: 20 |
A549: 3.5, MCF7: 5.0 and B16: 2.5 |
| Na-hydrazine and Citrate70 | Spherical; (5-50) |
MIC = 14-29 | - |
| SDS capped71 | Spherical; (45 ± 10) |
MBC = 5.0 ZOI = 7.3 |
- |
| Citrullus colocynthis leaves72 | Spherical; (31 |
- | Human epidermoid larynx carcinoma (HEp-2) cell line: 60.0 |
| Chemical reducing agents (Nanotechnologies, Inc)73 | Spherical; (15-21) | MBC = 75.0 | - |
| Inert gas condensation (IGC) process42 | Spherical; (16) | MBC = 60.0 | - |
| NaBH474 | Spherical; (10-20) | ZOI = 2.0-3.5 | - |
| D-glucose and hydrazine38 | Spherical; (10-15) | MIC, MBC = 25.0 | - |
| Syzygium cumini fruit extract75 | Spherical; (10-15) | - | Dalton lymphoma cells:100.0 |
| Chitosan76 | Spherical; (10-12) | MIC, MBC = 10.0 | HepG2: 6.09, Lu: 5.20, MCF-7: 5.71, KB: 3.74 |
| (Shanghai Huzheng Nanotechnology Company limited)40 | Spherical; (2-5) | MIC = 10.0 | Not available |
* Present article, MIC (Minimum Inhibitory concentration), MBC (Minimum bactericidal concentration) & ZOI (Zone of Inhibition).